C4 Therapeutics Inc
NASDAQ:CCCC

Watchlist Manager
C4 Therapeutics Inc Logo
C4 Therapeutics Inc
NASDAQ:CCCC
Watchlist
Price: 5.48 USD -1.62% Market Closed
Updated: May 25, 2024

C4 Therapeutics Inc
Long-Term Investments

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

C4 Therapeutics Inc
Long-Term Investments Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Long-Term Investments Analysis
Latest Figures & CAGR of Competitors

Company Long-Term Investments CAGR 3Y CAGR 5Y CAGR 10Y
C4 Therapeutics Inc
NASDAQ:CCCC
Long-Term Investments
$28m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Long-Term Investments
$305m
CAGR 3-Years
0%
CAGR 5-Years
-27%
CAGR 10-Years
10%
Gilead Sciences Inc
NASDAQ:GILD
Long-Term Investments
$359m
CAGR 3-Years
-15%
CAGR 5-Years
-31%
CAGR 10-Years
-1%
Amgen Inc
NASDAQ:AMGN
Long-Term Investments
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Long-Term Investments
$4.5B
CAGR 3-Years
496%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Long-Term Investments
$7B
CAGR 3-Years
25%
CAGR 5-Years
24%
CAGR 10-Years
29%

See Also

What is C4 Therapeutics Inc's Long-Term Investments?
Long-Term Investments
28m USD

Based on the financial report for Dec 31, 2023, C4 Therapeutics Inc's Long-Term Investments amounts to 28m USD.

What is C4 Therapeutics Inc's Long-Term Investments growth rate?
Long-Term Investments CAGR 1Y
-54%

Over the last year, the Long-Term Investments growth was -54%.